No increased risk of myocardial infarction among patients with ulcerative colitis or crohn's disease

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 10, 2011, Pages 875-880

  Osterman, Mark T ^a   Yang, Yu Xiao ^a   Brensinger, Colleen ^a   Forde, Kimberly A ^a   Lichtenstein, Gary R ^a   Lewis, James D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heart Disease; Immune Disorders; Inflammation; Intestine

Indexed keywords

ACETYLSALICYLIC ACID;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CROHN DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 80053133577     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.06.032     Document Type: Article

References (41)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
3. André P., Nannizzi-Alaimo L., Prasad S.K., et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002, 106:896-899.
4. del Rincón I., Williams K., Stern M.P., et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 12:2737-2745.
5. Solomon D.H., Karlson E.W., Rimm E.B., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
6. Fischer L.M., Schlienger R.G., Matter C., et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004, 93:198-200.
7. Wolfe F., Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 2008, 58:2612-2621.
8. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997, 145:408-415.
9. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999, 42:338-346.
10. Esdaile J.M., Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331-2337.
11. Hak A.E., Karlson E.W., Feskanich D., et al. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' Health Study. Arthritis Rheum 2009, 61:1396-1402.
12. Gelfand J.M., Neimann A.L., Shin D.B., et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006, 296:1735-1741.
13. Ekbom A., Helmick C.G., Zack M., et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992, 103:954-960.
14. Persson P.G., Bernell O., Leijonmarck C.E., et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996, 110:1339-1345.
15. Palli D., Trallori G., Saieva C., et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study. Gut 1998, 42:175-179.
16. Winther K.V., Jess T., Langholz E., et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003, 125:1576-1582.
17. Bernstein C.N., Wajda A., Blanchard J.F. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008, 6:41-45.
18. Yarur A.J., Deshpande A.R., Pechman D.M., et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106:741-747.
19. Lutgens E., Lievens D., Beckers L., et al. CD40 and its ligand in atherosclerosis. Trends Cardiovasc Med 2007, 17:118-123.
20. Danese S., Papa A., Saibeni S., et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007, 102:174-186.
21. The General Practice Research Database: a guide for researchers August 2003.
22. Lewis J.D., Brensinger C., Bilker W.B., et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002, 11:211-218.
23. Van Staa T.P., Cooper C., Brusse L.S., et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003, 125:1591-1597.
24. Jick H., Derby L.E., Gurewich V., et al. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996, 16:321-326.
25. Jick H., Vasilakis C., Derby L.E. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension. Epidemiology 1997, 8:446-448.
26. Meier C.R., Jick S.S., Derby L.E., et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998, 351:1467-1471.
27. Meier C.R., Derby L.E., Jick S.S., et al. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999, 281:427-431.
28. Lewis J.D., Bilker W.B., Weinstein R.B., et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005, 14:443-451.
29. Agata N.N., Carvalheiro J.N., Chen J., et al. Report of a WHO expert committee. WHO technical report series no. 845 1995, 213-244. World Health Organization, Geneva, Switzerland.
30. Card T., Hubbard R., Logan R.F. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 2003, 125:1583-1590.
31. Yang Y.X., Hennessy S., Lewis J.D. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004, 127:1044-1050.
32. Bernstein C.N., Blanchard J.F., Houston D.S., et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
33. Miehsler W., Reinisch W., Valic E., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 2004, 53:542-548.
34. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:2272-2280.
35. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375:657-663.
36. Weil J., Colin-Jones D., Langman M., et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995, 310:827-830.
37. García-Rodríguez L.A., Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001, 12:88-93.
38. Solomon D.H., Avorn J., Katz J.N., et al. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3790-3798.
39. Suissa S., Bernatsky S., Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006, 55:531-536.
40. Davis J.M., Kremers H.M., Crowson C.S., et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007, 56:820-830.
41. Naranjo A., Sokka T., Descalzo M.A., et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008, 10:R30.